Javascript must be enabled to continue!
Blood Donors Positive for HBsAg and Negative for Anti‐HBc Antibody
View through CrossRef
Abstract. From January 1980 to December 1983,989,907 blood donations were screened for HBsAg. A total of 1,345 was found HBsAg positive; 33 of whom were negative for anti‐HBc (2.45%); in 10 cases HBeAg was present at a low level along with HBsAg. 2 of the 33 subjects were lost to follow‐up. Late serum samples were available for 28 blood donors, and clinical and biological data only were known for the 3 others. An evolution of HBV markers was observed in each case; anti‐HBc antibody became positive in 24 subjects (the 4 remaining subjects had a very short follow‐up); HBeAg was positive at a high titer in 18 subjects and seroconversion to anti‐HBe was observed in 7 individuals; HBsAg concentration increased in 21 subjects from 2 to 4,000 times and decreased in the 7 others. Seroconversion to anti‐HBs was observed in 8 individuals. According to these serological, biological and clinical findings, different outcomes were observed: in 6 subjects too short a follow‐up was available to allow appropriate classification, but there was evidence to suggest all probably developed clinical hepatitis; in 6 subjects asymptomatic hepatitis with rapid loss of HBsAg occurred; in 2 subjects asymptomatic hepatitis with the persistence of HBsAg at a low level and seroconversion to anti‐HBe occurred; and in 17 subjects clinical hepatitis developed. These observations establish that most of the 33 blood donors were infectious at the time of their blood donation, and that anti‐HBc antibody screening must not replace HBsAg screening for blood donations.
Title: Blood Donors Positive for HBsAg and Negative for Anti‐HBc Antibody
Description:
Abstract.
From January 1980 to December 1983,989,907 blood donations were screened for HBsAg.
A total of 1,345 was found HBsAg positive; 33 of whom were negative for anti‐HBc (2.
45%); in 10 cases HBeAg was present at a low level along with HBsAg.
2 of the 33 subjects were lost to follow‐up.
Late serum samples were available for 28 blood donors, and clinical and biological data only were known for the 3 others.
An evolution of HBV markers was observed in each case; anti‐HBc antibody became positive in 24 subjects (the 4 remaining subjects had a very short follow‐up); HBeAg was positive at a high titer in 18 subjects and seroconversion to anti‐HBe was observed in 7 individuals; HBsAg concentration increased in 21 subjects from 2 to 4,000 times and decreased in the 7 others.
Seroconversion to anti‐HBs was observed in 8 individuals.
According to these serological, biological and clinical findings, different outcomes were observed: in 6 subjects too short a follow‐up was available to allow appropriate classification, but there was evidence to suggest all probably developed clinical hepatitis; in 6 subjects asymptomatic hepatitis with rapid loss of HBsAg occurred; in 2 subjects asymptomatic hepatitis with the persistence of HBsAg at a low level and seroconversion to anti‐HBe occurred; and in 17 subjects clinical hepatitis developed.
These observations establish that most of the 33 blood donors were infectious at the time of their blood donation, and that anti‐HBc antibody screening must not replace HBsAg screening for blood donations.
Related Results
Evaluation of Isolated Anti-HBc Positivity in Patients Considered for Hepatitis B Diagnosis: 8.5 Years of Data
Evaluation of Isolated Anti-HBc Positivity in Patients Considered for Hepatitis B Diagnosis: 8.5 Years of Data
Background: Hepatitis B virus (HBV) infection is a global health problem. Isolated anti-hepatitis B core (HBc) serologic pattern is the most common atypical serologic profile and i...
HBsAg ≤ 135 IU/mL or HBcrAg ≤ 3.6 logU/mL was associated with HBsAg loss after nucleos(t)ide analogue cessation
HBsAg ≤ 135 IU/mL or HBcrAg ≤ 3.6 logU/mL was associated with HBsAg loss after nucleos(t)ide analogue cessation
Abstract
Background
Since hepatitis B surface antigen (HBsAg) loss is rarely achieved with nucleos(t)ide analogue (NA) treatment, most patients require life-long NA treatme...
Abstract P1-15-02: Low incidence of hepatitis B reactivation after chemotherapy in Japanese breast cancer patients with resolved HBV
Abstract P1-15-02: Low incidence of hepatitis B reactivation after chemotherapy in Japanese breast cancer patients with resolved HBV
Abstract
Background: Recently, chemotherapy-induced reactivation of hepatitis B virus (HBV) has been reported not only in patients with HBV surface antigen positive ...
[RETRACTED] Guardian Blood Balance –Feel the difference Guardian Blood Balance makes! v1
[RETRACTED] Guardian Blood Balance –Feel the difference Guardian Blood Balance makes! v1
[RETRACTED]Guardian Blood Balance Reviews (Works Or Hoax) Does Guardian Botanicals Blood Balance AU Really Works? Read Updated Report! Diabetes and Hypertension is such a health p...
Predictors of False-Negative Axillary FNA Among Breast Cancer Patients: A Cross-Sectional Study
Predictors of False-Negative Axillary FNA Among Breast Cancer Patients: A Cross-Sectional Study
Abstract
Introduction
Fine-needle aspiration (FNA) is commonly used to investigate lymphadenopathy of suspected metastatic origin. The current study aims to find the association be...
Infections of Hepatitis B and C and Malaria Plasmodium Falciparum among Blood Donors in Ife East Local Government Area, Ile Ife, Osun State, Nigeria
Infections of Hepatitis B and C and Malaria Plasmodium Falciparum among Blood Donors in Ife East Local Government Area, Ile Ife, Osun State, Nigeria
Endemic regions for malaria are endemic for other infectious diseases that might affect the malaria infection. Infection with
hepatitis B virus (HBV) and hepatitis C virus (HCV) ar...
Mother to child blocking of hepatitis B virus and post vaccination serological test in Qinghai province
Mother to child blocking of hepatitis B virus and post vaccination serological test in Qinghai province
Background
In 2016, Qinghai Province and the Asian Liver Center of Stanford University in the United States cooperated to carry out a one-year project of hepatitis B mother-to-chil...
Blood Cross Matching Without Anti-Human Globulin (AHG) and Bovine Serum: A New Interest for an Old Idea
Blood Cross Matching Without Anti-Human Globulin (AHG) and Bovine Serum: A New Interest for an Old Idea
Abstract
Introduction
Transfusion medicine promotes the safety of blood transfusions by rigorously testing to eliminate risks of infection and hemolytic. The efficacy (to correct ...

